World To Exhaust Existing Supply Of Sanofi Pasteur’s Snakebite Anti-Venom Next Year, MSF Warns

Associated Press: Doctors Without Borders: snakebite treatment running out
“Doctors Without Borders says the world will run out of one of the most effective treatments for snakebites next year, putting the lives of tens of thousands of people at risk, mostly in developing countries…” (Cheng, 9/7).

Deutsche Welle: Report: snakebite treatment in short supply
“…Existing stockpiles of the anti-venom Fav-Afrique produced by Sanofi Pasteur will expire in June. The company stopped producing the anti-venom last year and has since switched to making a rabies treatment at its facilities…” (9/7).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.